Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Citigroup Downgrades GE HealthCare Techs to Neutral, Lowers Price Target to $83

Author: Benzinga Newsdesk | October 07, 2025 07:26am
Citigroup analyst Joanne Wuensch downgrades GE HealthCare Techs (NASDAQ:GEHC) from Buy to Neutral and lowers the price target from $93 to $83.

Posted In: GEHC

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist